TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8356866

Group type: COMPARATOR
Intervention: High-flow anaesthesia using a partial rebreathing system without carbon dioxide absorption (Mapleson D)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Medium-flow anaesthesia using a circle system with carbon dioxide absorption
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-flow anaesthesia using a circle system with carbon dioxide absorption
Number of subjects: 30
Study: 2868255

Group type: EXPERIMENTAL
Intervention: Dietary manipulation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 31797330

Group type: EXPERIMENTAL
Intervention: Cognitive remediation-enabled cognitive behaviour therapy (CR-CBT)
Number of subjects: 4
Study: 30043208

Group type: EXPERIMENTAL
Intervention: Bevacizumab biosimilars (MIL60, BAT1706, IBI305)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bevacizumab-EU
Number of subjects: 0
Study: 27052561

Group type: EXPERIMENTAL
Intervention: High-resistance training (80% 1 RM, 2 × 10-15 repetitions)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Low-resistance training (20% 1 RM, 1 × 80-100 repetitions)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mixed low-resistance training (20% 1 RM followed by 40% 1 RM)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Overall resistance training (all groups combined)
Number of subjects: 56
Study: 24748630

Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg every 4 weeks (q4wks)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg every 4 weeks (q4wks)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Golimumab (50 mg or 100 mg) from week 24 onward
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Golimumab (50 mg or 100 mg)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Methotrexate (concomitant treatment)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study: 23764521

Group type: EXPERIMENTAL
Intervention: Aripiprazole 2 mg/day (Phase 1) and 5 mg/day (Phase 2)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Aripiprazole 2 mg/day (Phase 2)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 221
Study: 19580465

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 10 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 5 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Alendronate (ALN) for 5 years plus placebo for 5 years
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy population
Number of subjects: 30
Study: 18664276

Group type: EXPERIMENTAL
Intervention: Tai Chi (10 modified forms from classical Yang style Tai Chi), 60-minute sessions, twice weekly for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Attention control (wellness education and stretching), 60-minute sessions, twice weekly for 12 weeks
Number of subjects: 40
Study: 16860606

Group type: EXPERIMENTAL
Intervention: On-pump CABG surgery (group I, n=24 patients)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Off-pump CABG (group II, n=18 patients)
Number of subjects: 42
Study: 12607326

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg bid, Amoxicillin 750 mg bid, Clarithromycin 200 mg bid
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg bid, Amoxicillin 750 mg bid, Clarithromycin 400 mg bid
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, Amoxicillin 750 mg bid, Clarithromycin 400 mg bid
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, Amoxicillin 1,000 mg, Clarithromycin 500 mg bid
Number of subjects: 3
Study: 11391837

Group type: EXPERIMENTAL
Intervention: zalcitabine 2.25 mg and saquinavir 1800 mg per day
Number of subjects: 24
Study: 8924822

Group type: EXPERIMENTAL
Intervention: aprotinin inhalations thrice a day for 4-5 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: soda (placebo)
Number of subjects: 52
Study: 1738222

Group type: EXPERIMENTAL
Intervention: Gastric feeding (17 patients)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Postpylorus feeding (16 patients)
Number of subjects: 33
Study: 6509283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phenobarbitone 30 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phenobarbitone 100 mg
Number of subjects: 60
Study: 30188571

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 5204

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 5204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5204

Group type: EXPERIMENTAL
Intervention: Tofacitinib (both dosages)
Number of subjects: 5204
Study: 28722569

Group type: EXPERIMENTAL
Intervention: Annual mass azithromycin distributions (3 treatments during high-transmission season)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Biannual mass azithromycin distributions (6 treatments: 3 during high-transmission season and 3 during low-transmission season)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Annual mass azithromycin alone
Number of subjects: 24
Study: 25732409

Group type: EXPERIMENTAL
Intervention: Bedside polymerase chain reaction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Culture
Number of subjects: 0
Study: 23905377

Group type: EXPERIMENTAL
Intervention: Epidural combined electroacupuncture (EA) group (Group B) with continuous EA at Zusanli (ST36) and Sanyinjiao (SP6) at a frequency of 30-100 Hz.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural anesthesia group (Group A)
Number of subjects: 40
Study: 21543959

Group type: EXPERIMENTAL
Intervention: Comprehensive psychosocial support intervention
Number of subjects: 406

Group type: COMPARATOR
Intervention: Nursing home placement
Number of subjects: 406
Study: 19332970

Group type: EXPERIMENTAL
Intervention: Bacillus coagulans GBI‐30, 6086
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 16964669

Group type: EXPERIMENTAL
Intervention: Interferon-alpha-2b treatment during vaccination (Group A, 12 patients)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Hepatitis B vaccine without interferon (Group B, 25 patients)
Number of subjects: 37
Study: 14996138

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticonvulsants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 11514377

Group type: EXPERIMENTAL
Intervention: Blood phobic subjects during head-up tilt
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control subjects during head-up tilt
Number of subjects: 11
Study: 9287255

Group type: EXPERIMENTAL
Intervention: Psychological treatment conditions for IBS
Number of subjects: 84
Study: 8330445

Group type: EXPERIMENTAL
Intervention: L‐thyroxine therapy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 3090332

Group type: COMPARATOR
Intervention: Bolus MMC with no further treatment (Group A)
Number of subjects: 2873

Group type: COMPARATOR
Intervention: Oral futraful for one year without MMC induction (Group C)
Number of subjects: 2873

Group type: COMPARATOR
Intervention: Bolus MMC injection and oral futraful (Group B)
Number of subjects: 2873

Group type: EXPERIMENTAL
Intervention: Bolus MMC and oral futraful for one year (Group B)
Number of subjects: 2873
Study: 30625042

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) patch treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platelet-derived patch treatment and PRP injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional advanced wound dressings
Number of subjects: 0
Study: 28298661

Group type: EXPERIMENTAL
Intervention: Antegrade cerebral perfusion (ACP) with moderate hypothermia (24°C)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Deep hypothermic circulatory arrest (DHCA) with craniocerebral hypothermia (18°C)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Antegrade cerebral perfusion (ACP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Deep hypothermic circulatory arrest (DHCA)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Quality of life (QoL)
Number of subjects: 58
Study: 25060944

Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 23570295

Group type: EXPERIMENTAL
Intervention: Rely X Luting Plus (3M ESPE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Maxcem Elite (Kerr Corporation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ketac Cem (3M ESPE)
Number of subjects: 30
Study: 22192419

Group type: EXPERIMENTAL
Intervention: OSIT-J test in patients with PD
Number of subjects: 145

Group type: COMPARATOR
Intervention: OSIT-J test in normal control subjects
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: OSIT-J test in patients with MSA-P
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: OSIT-J test in patients with PSP
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: OSIT-J test for discriminating PD from normal control
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: OSIT-J test for discriminating PD from MSA-P
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: OSIT-J test for discriminating PD from PSP
Number of subjects: 145
Study: 19501932

Group type: EXPERIMENTAL
Intervention: Combination treatment with vitamin K2 (VK; menatetrenone; 45 mg/day) and angiotensin-converting enzyme inhibitor (ACE-I; perindopril; 4 mg/day) for 36-48 months
Number of subjects: 87

Group type: COMPARATOR
Intervention: Vitamin K2 (VK; menatetrenone; 45 mg/day)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme inhibitor (ACE-I; perindopril; 4 mg/day)
Number of subjects: 87
Study: 16492843

Group type: EXPERIMENTAL
Intervention: Continuous pulse oximetry (CPOX) monitoring
Number of subjects: 1219

Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 1219

Group type: EXPERIMENTAL
Intervention: CPOX monitoring
Number of subjects: 1219
Study: 15270994

Group type: EXPERIMENTAL
Intervention: Music lessons (keyboard or voice)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Drama lessons
Number of subjects: 144

Group type: COMPARATOR
Intervention: No lessons
Number of subjects: 144
Study: 11865966

Group type: EXPERIMENTAL
Intervention: Roflumilast (500 microg/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9832292

Group type: EXPERIMENTAL
Intervention: N-acetyl-aspartyl-glutamic acid (NAAGA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 10
Study: 8587272

Group type: EXPERIMENTAL
Intervention: Pravastatin (PVS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 2475682

Group type: EXPERIMENTAL
Intervention: Sustained-release verapamil (240 mg once daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 26
Study: 979075

Group type: EXPERIMENTAL
Intervention: Proximal selective vagotomy with pyloroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proximal selective vagotomy without pyloroplasty
Number of subjects: 0
Study: 30753203

Group type: EXPERIMENTAL
Intervention: Cyclic inflation and deflation of pneumatic cuffs wrapped around the subject's thighs
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 22
Study: 28301686

Group type: EXPERIMENTAL
Intervention: Non-operative treatment with daily site-specific oral hygiene using fluoridated toothpaste, professional topical fluoride treatment, and dietary advice.
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Non-operative treatment
Number of subjects: 39
Study: 26371618

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Active control condition (ACC)
Number of subjects: 92
Study: 23400564

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg plus gp100 vaccine
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg plus placebo
Number of subjects: 676

Group type: COMPARATOR
Intervention: gp100 vaccine plus placebo
Number of subjects: 676
Study: 21557816

Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrate
Number of subjects: 19
Study: 19725594

Group type: EXPERIMENTAL
Intervention: CNTO 528 at 0.03 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CNTO 528 at 0.09 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CNTO 528 at 0.3 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CNTO 528 at 0.9 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: CNTO 528
Number of subjects: 24
Study: 17724294

Group type: EXPERIMENTAL
Intervention: Statin withdrawal for the first 3 days after admission (n = 46)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/day (n = 43)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Statin withdrawal compared to non-randomized patients without previous statin therapy (n = 126)
Number of subjects: 215
Study: 15134708

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection into the right trapezius muscle
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Isotonic saline injection into the right trapezius muscle
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection into the right temporalis muscle
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Isotonic saline injection into the right temporalis muscle
Number of subjects: 14
Study: 11475708

Group type: EXPERIMENTAL
Intervention: Philips Jordan HP735 electric toothbrush
Number of subjects: 49

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 49
Study: 9728842

Group type: EXPERIMENTAL
Intervention: 2 mg of intrathecal ropivacaine plus sufentanil 10 microg (R2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4 mg of intrathecal ropivacaine plus sufentanil 10 microg (R4)
Number of subjects: 48

Group type: COMPARATOR
Intervention: 2.5 mg of intrathecal bupivacaine plus sufentanil 10 microg (B)
Number of subjects: 48
Study: 8293822

Group type: EXPERIMENTAL
Intervention: Transcervical intrafallopian transfer of zygotes
Number of subjects: 145

Group type: COMPARATOR
Intervention: Intrauterine transfer of cleaved embryos
Number of subjects: 145
Study: 29368880

Group type: EXPERIMENTAL
Intervention: Exercise group (N=20)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Compression and exercise group (N=20)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (N=20)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Compression therapy group (N=20)
Number of subjects: 80
Study: 26578306

Group type: EXPERIMENTAL
Intervention: Anterior referencing (AR) technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Posterior referencing (PR) technique
Number of subjects: 20
Study: 24445098

Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) approach
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-Directed (SD) practices
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reflective Adaptive Process (RAP) approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Self-Directed practices)
Number of subjects: 40
Study: 23334115

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (10 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% (10 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no wound infiltration)
Number of subjects: 60
Study: 20464949

Group type: EXPERIMENTAL
Intervention: No tourniquet used (Group I)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Tourniquet used, deflated for hemostasis after component insertion (Group II)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Tourniquet used, deflated after wound closure (Group III)
Number of subjects: 84
Study: 18471341

Group type: EXPERIMENTAL
Intervention: lornoxicam (16 mg, i.v.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 16311286

Group type: EXPERIMENTAL
Intervention: Ephedrine 50 mg in saline 0.9% w/v, 500 ml at 999 ml h(‐1)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Phenylephrine 500 microg in saline 0.9% w/v, 500 ml at 999 ml h(‐1)
Number of subjects: 2
Study: 12559808

Group type: EXPERIMENTAL
Intervention: Vaxigrip
Number of subjects: 2150

Group type: COMPARATOR
Intervention: Fluad
Number of subjects: 2150

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 2150
Study: 10810841

Group type: EXPERIMENTAL
Intervention: Written statements of expert witnesses provided before testimony
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Written statements of expert witnesses provided after testimony
Number of subjects: 0

Group type: COMPARATOR
Intervention: No written statements of expert witnesses
Number of subjects: 0
Study: 8856257

Group type: EXPERIMENTAL
Intervention: Dialysis with dialysate containing 128 mEq/l sodium
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dialysis with dialysate containing 137 mEq/l sodium
Number of subjects: 22
Study: 1520833

Group type: EXPERIMENTAL
Intervention: GORE-TEX
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Marlex
Number of subjects: 17
Study: 6527754

Group type: EXPERIMENTAL
Intervention: 0.125 mg brotizolam
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 2.5 mg nitrazepam
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 31552750

Group type: EXPERIMENTAL
Intervention: 5F ureteral stent
Number of subjects: 110

Group type: COMPARATOR
Intervention: 6F ureteral stent
Number of subjects: 110
Study: 30148660

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Children with ADHD (no medication)
Number of subjects: 136
Study: 26447193

Group type: EXPERIMENTAL
Intervention: Guaranteed pay‐out (GPO) incentives
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lottery incentives
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 36
Study: 24467861

Group type: EXPERIMENTAL
Intervention: Meaning‐Centered Group Psychotherapy (MCGP‐CS)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 168
Study: 21247745

Group type: EXPERIMENTAL
Intervention: Atenolol (after one-week treatment)
Number of subjects: 10
Study: 20545786

Group type: EXPERIMENTAL
Intervention: Unsweetened ice-popsicle
Number of subjects: 31

Group type: COMPARATOR
Intervention: Toy
Number of subjects: 31
Study: 18282613

Group type: EXPERIMENTAL
Intervention: Fibrin glue (Quixil, OMRIX biopharmaceuticals) applied to tonsillar beds at the end of the operation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (tonsillectomy without fibrin glue)
Number of subjects: 168
Study: 15988705

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/d
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Coadministration of raloxifene 60 mg/d and simvastatin 10 mg/d
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 12028719

Group type: EXPERIMENTAL
Intervention: Integrated display
Number of subjects: 39

Group type: COMPARATOR
Intervention: Functionally-separate display
Number of subjects: 39

Group type: COMPARATOR
Intervention: Spatially-separate display
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Complex scenarios
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Time on watch
Number of subjects: 39
Study: 10336572

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Diltiazem 200 mg
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Diltiazem 300 mg
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Mibefradil 50 mg
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Mibefradil 100 mg
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control (baseline beta-adrenoceptor blocker treatment)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Mibefradil (both doses)
Number of subjects: 335
Study: 7573719

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice a day for 10 days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice a day for 14 days
Number of subjects: 69
Study: 2007671

Group type: EXPERIMENTAL
Intervention: Topical immunotherapy (diphenylcyclopropenone)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control (unilateral treatment side)
Number of subjects: 139
Study: 7132464

Group type: EXPERIMENTAL
Intervention: Experimental clinics with age-specific checklists and weekly seminars
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 0
Study: 30740742

Group type: EXPERIMENTAL
Intervention: SBSP with protocol
Number of subjects: 23

Group type: COMPARATOR
Intervention: SBSP without protocol
Number of subjects: 23
Study: 29654498

Group type: EXPERIMENTAL
Intervention: Coffee robusta sachet dissolved in 100 ml of hot water
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Coffee arabica (Qahwa)
Number of subjects: 300

Group type: COMPARATOR
Intervention: 100 ml water only
Number of subjects: 300
Study: 27364307

Group type: EXPERIMENTAL
Intervention: 6-cm quilting
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 3-cm quilting
Number of subjects: 36

Group type: COMPARATOR
Intervention: nonquilting
Number of subjects: 36
Study: 24401715

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 22769066

Group type: EXPERIMENTAL
Intervention: CT-based hematoma puncture and partial aspiration in the emergency department followed by craniectomy (Group A)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Craniectomy only (Group B)
Number of subjects: 36
Study: 20035353

Group type: EXPERIMENTAL
Intervention: RAPID protocol (55 patients laparoscopic, 25 patients open)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Traditional treatment (15 patients laparoscopic, 22 patients open)
Number of subjects: 117
Study: 18672164

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Control (no CRT)
Number of subjects: 813
Study: 16160619

Group type: EXPERIMENTAL
Intervention: St John's wort (900 mg/d)
Number of subjects: 135